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O B J E C T I V E S The goal of this study was to assess the diagnostic performance of cardiac magnetic
resonance (CMR) compared with endomyocardial biopsy in patients with suspected acute myocarditis
(AMC) and chronic myocarditis (CMC).
B A C KG ROUND Several studies have reported an encouraging diagnostic performance of CMR in
myocarditis. However, the comparison of CMR with clinical data only and the use of preselected patient
populations are important limitations of the majority of these reports.
METHOD S One hundred thirty-two consecutive patients with suspected AMC (deﬁned by symptoms
14 days; n  70) and CMC (deﬁned by symptoms 14 days; n  62) were included. Patients underwent
cardiac catheterization with left ventricular endomyocardial biopsy and CMR, including T2-weighted imaging
for assessment of edema, T1-weighted imaging before and after contrast administration for evaluation of
hyperemia, and assessment of late gadolinium enhancement. CMR results were considered to be consistent
with the diagnosis of myocarditis if 2 of 3 CMR techniques were positive.
R E S U L T S Within the total population, myocarditis was the most common diagnosis on endomyo-
cardial biopsy analysis (62.9%). Viral genomes were detected in 30.3% (40 of 132) of patients within the
total patient population and signiﬁcantly more often in patients with AMC than CMC (40.0% vs. 19.4%;
p  0.013). For the overall cohort of patients with either suspected AMC or CMC, the diagnostic
sensitivity, speciﬁcity, and accuracy of CMR were 76%, 54%, and 68%, respectively. The best diagnostic
performance was observed in patients with suspected AMC (sensitivity, 81%; speciﬁcity, 71%; and
accuracy, 79%). In contrast, diagnostic performance of CMR in suspected CMC was found to be
unsatisfactory (sensitivity, 63%; speciﬁcity, 40%; and accuracy, 52%).
CONC L U S I O N S The results of this study underline the usefulness of CMR in patients with
suspected AMC. In contrast, the diagnostic performance of CMR in patients with suspected CMC might
not be sufﬁcient to guide clinical management. (J Am Coll Cardiol Img 2012;5:513–24) © 2012 by the
American College of Cardiology Foundation
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514T
he diagnosis of myocarditis and myocardial
inflammation represents an enormous clinical
challenge. Several clinical signs and symptoms
have been described to be associated with
yocarditis, such as flu-like or angina-like symp-
oms, signs of heart failure, or subclinical presenta-
ion (1,2). However, there are no unambiguously
efined clinical criteria for the diagnosis of myocar-
itis and myocardial inflammation.
See page 525
Endomyocardial biopsy (EMB) is widely consid-
ered to be the gold standard for diagnosis of
myocarditis, especially due to standardized immu-
nohistological criteria (3). Recently, several studies
have suggested cardiac magnetic resonance (CMR)
as a promising noninvasive diagnostic alternative in
patients with suspected myocarditis (4–
13). Three CMR techniques have been
applied in myocarditis: 1) late gadolinium
enhancement (LGE) sequences for detec-
tion of myocardial necrosis and/or fibrosis;
2) T2-weighted images for assessment of
myocardial edema; and 3) T1-weighted
sequences before and after contrast injec-
tion for detection of myocardial hyperemia.
A pooled analysis of studies on CMR in
myocarditis (4–12) resulted in a consensus
paper and recommendations on the use of
CMR for myocarditis (14). Within this
consensus report, the “Lake Louise crite-
ria” for CMR diagnosis of myocarditis
were proposed, stating that CMR findings
are consistent with the diagnosis of myo-
arditis if 2 of 3 of the above-mentioned sequences
ere found to be positive/pathological.
However, the retrospective nature, the small
ample size (5,8,10–12), the comparison of CMR
esults with clinical data only (5,8,10–12), pre-
elected patient populations, and the use of only 1
r 2 of 3 proposed imaging techniques (4,8–10,12)
re important limitations of most of the reports on
hich the consensus paper is based on. Moreover,
he diagnostic performance of CMR as suggested
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In this study, we applied currently proposed
MR techniques for image acquisition, analysis,
nd interpretation (14) prospectively in an unse-
ected patient cohort with both suspected acute
yocarditis (AMC) and chronic myocarditis
CMC). The goal of this study was to evaluate the
iagnostic performance of comprehensive CMR for
yocarditis in a real-world clinical setting com-
ared with EMB.
M E T H O D S
Patients and study protocol. In this prospective
study, patients with clinical suspicion of myocarditis
were included. Myocarditis was suspected in
patients who fulfilled all of the following criteria:
1) new onset or persisting symptoms suggestive of
myocarditis (shortness of breath, effort intolerance,
fatigue, palpitations, or chest pain); 2) evidence of
recent or ongoing myocardial damage (left ventric-
ular dysfunction, electrocardiogram abnormalities,
or elevated troponin levels); 3) history of systemic
viral disease; and 4) exclusion of relevant coronary
artery disease on selective angiography. These in-
clusion criteria were adjusted from the currently
proposed criteria for CMR in myocarditis (14).
Inclusion criteria were established by detailed as-
sessment of patients’ medical history, physical ex-
amination, echocardiography for assessment of left
ventricular dysfunction, and blood samples to de-
termine troponin levels. Assessment protocols for
CMR and catheterization are outlined in the fol-
lowing discussion.
Patients with contraindication to cardiac cathe-
terization, EMB, or CMR were excluded. In addi-
tion, patients with nondiagnostic EMB or CMR
were not included in the final analysis.
Patients were divided into 2 groups according to
duration of symptoms from onset to hospital ad-
mission to separate patients with suspected AMC
(symptoms 14 days [group 1]) from those with
suspected CMC (symptoms 14 days [group 2]).
Within group 1, a subgroup of patients with sus-
pected “infarct-like myocarditis” was further de-
fined according to the following criteria: 1) elevated
troponin levels; 2) chest pain; and 3) ST-segment
elevation.
The study was approved by the local ethics
committee, and all patients provided written in-B B R E V I A T I O N S
N D A C R O N YM S
AMC acute myocarditis
CMC chronic myocarditis
CMR cardiac magnetic
resonance
EMB endomyocardial biop
ER edema ratio
gRE global relative
enhancement
LGE late gadolinium
enhancement
NPV negative predictive vformed consent.
m e TS  transverse sections.
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515CMR imaging and analyses. CMR was performed
using a 1.5-T magnetic resonance scanner (Gy-
roscan Intera CV, Philips Medical Systems, Best,
the Netherlands). CMR assessment of myocardial
inflammation/myocarditis included determination
of: myocardial edema or rather edema ratio (ER);
myocardial hyperemia or rather global relative en-
hancement (gRE); and myocardial fibrosis/necrosis
or rather myocardial LGE. All CMR protocols for
image acquisition, sequence and setup adjustments,
and analyses were adapted from the previously
published consensus paper (14) and are summarized
in Table 1.
Image analysis was performed by experienced,
blinded operators. For all quantitative analyses,
certified CMR image evaluation software was used
Table 1. CMR Imaging Sequences and Parameters
Cine Imaging
Sequence Steady-state free precession
Triggering Gated
Free breathing/breath-hold Breath-hold
Coil setup 5-element phased array
Slices acquired Vertical long axis, 4-chamber view,
SAX covering LV and RV
Repetition time, ms 3.6
Echo time, ms 1.8
Inversion time, ms –
Echo train length, ms –
Flip angle, ° 60
Slice thickness 8
Field of view, cm 280–380
Partial ﬁeld of view 1
Matrix, pixels 240  236
3D  3-dimensional; CMR  cardiac magnetic resonance; LGE  late gadoliniu
Figure 1. T2-Weighted MR Imaging and Assessment of Global M
(Left) T2-weighted magnetic resonance (MR) images demonstrati
(short-axis slice). (Right) Computer-aided signal intensity (SI) ana
tive SI normalized to skeletal muscle (blue indicates an SI ratio o
low indicates normal 1.9). The yellow contour marks the region of(cmr42, Circle Cardiovascular Imaging Inc., Cal-
gary, Alberta, Canada). Standard methods of left
ventricular functional analysis were performed by
manual tracing of the endocardial and epicardial
contours. Assessment of ER (Figs. 1 and 2) (5,7,
14,15), gRE (Fig. 3) (7,8,14), and LGE (Fig. 4)
(15) has been described previously. A detailed
description of image acquisition and analyses pro-
tocols applied in this study is contained in the
Online Appendix.
According to the Lake Louise criteria (14),
CMR findings were considered to be consistent
with myocardial inflammation/myocarditis if at
least 2 of 3 of the above-mentioned imaging criteria
(ER, gRE, and LGE) were found to be patholog-
ical (i.e., the 2 of 3 approach).
Edema Imaging Hyperemia Imaging
-weighted triple inversion
recovery
T1-weighted fast spin
echo saturation bands
across atria
3D inve
turb
ted Nongated Gated
ath-hold Free breathing Breath-
dy coil Body coil 5-elem
X covering LV and RV 5 identical TS covering entire
myocardium, pre-contrast
and post-contrast (15 s)
injection
Vertica
4-ch
cove
R-R interval 1 R-R interval 4.8
0 15 2.3
0 – Consta
3 –
90 15
8 10
0–400 350–400 350–40
5 1 1
6  256 512  512 256 
nhancement; LV  left ventricle; RV  right ventricle; SAX  short-axis sections;
ardial Edema
global myocardial edema in a patient with acute myocarditis
s of the T2-weighted images with color-coded display of rela-
yocardium/skeletal muscle 1.9, indicating edema; green/yel-LGE Imaging
T2 rsion recovery,
o gradient echo
Ga
Bre hold
Bo ent phased array
SA l long axis,
amber view, SAX
ring LV and RV
2 
10
15 ntly adjusted
33
90
10
35 0
0.7
25 256yoc
ng
lysi
f minterest for SI assessment of the skeletal muscle.
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516Coronary angiography and EMBs. Selective coronary
ngiograms of the left and the right coronary artery
ere acquired. Significant coronary artery disease
as defined by coronary artery stenosis 50% in at
east 1 coronary artery segment. For EMB sam-
ling, a myocardial biopsy forceps (Teleflex Medi-
al Tuttlingen GmbH, Tuttlingen, Germany) was
sed. Five to 6 EMB specimens were taken from
he left ventricle under fluoroscopic guidance. EMB
pecimens were taken from different locations
ithin the left ventricle.
EMB analysis. All histological, immunohistological,
and molecular pathological analyses diagnosing
myocardial inflammation and viral infections were
performed at the Department of Molecular Pathol-
ogy, University Hospital Tuebingen (Tuebingen,
Germany) as previously described (4,6,16,17). In
brief, myocardial inflammation was defined as the
Figure 3. T1-Weighted MR Imaging and Assessment of Myocard
Pre-contrast (left) and post-contrast (right) axial T1-weighted spin e
enhancement from the mean signal intensities within the manually
right erector spinae muscle (yellow contour). An additional saturat
ﬂowing blood. In this patient, image analysis revealed a global rela
Figure 2. T2-Weighted Imaging and Assessment of Focal Myoca
T2-weighted magnetic resonance (MR) imaging in a patient with focal are
quantitative assessment detects a focal subepicardial high SI (SI 2
indicating regional myocardial edema in this patient (right).mation. Abbreviation as in Figure 1.detection of 14 infiltrating leukocytes/mm2
(CD3 T-lymphocytes and/or CD68 macro-
phages) in addition to enhanced human leukocyte
antigen class II expression in professional antigen-
presenting immune cells.
AMC requiring myocyte injury/necrosis was dif-
ferentiated from CMC, which was defined by the
following criteria: absence of myocyte necrosis but
detection of interstitial fibrosis, 14 infiltrating
leukocytes/mm2 (CD3 T-lymphocytes and/or
D68 macrophages), and degeneration of neigh-
oring myocytes, being morphologically consistent
ith the formerly defined “borderline” myocarditis.
Nested (RT-) polymerase chain reaction for the
etection of viral genomes was performed as previ-
usly described (4,6). Masson trichrome staining
llowed the visualization of fibrosis. For the diag-
osis of hypertrophic cardiomyopathy (18,19) and
yperemia
images of the same slice used to calculate global relative
lined borders around the left myocardium (purple contour) and
ection is positioned across the atria to reduce signal from slow-
enhancement ratio 4, indicating myocardial hyperemia/inﬂam-
l Edema
visually apparent high signal intensity (SI) (short-axis slice, [left]). Semi-
above the SI of normal myocardium, blue contour) (red overlay),ial H
cho
out
ion s
tiverdia
as of
SDs
m
a
C
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517amyloidosis (20), additional electron microscopy
and Congo red staining, respectively, were per-
formed. The diagnosis of dilated cardiomyopathy
was primarily made in association with additional
angiographic and CMR data, especially when
histopathological data were ambiguous for di-
lated cardiomyopathy.
Figure 4. Assessment of Myocardial Fibrosis/Necrosis/Scarring
by Visualization of Late Enhancement on MR
Late gadolinium enhancement imaging of a patient with
active myocarditis on endomyocardial biopsy shows focal late
gadolinium enhancement (arrows) within the lateral wall of
the left ventricle (long-axis view). Abbreviation as in Figure 1.
Figure 5. Histopathology and Immunohistology in Normal Hear
Histopathology and immunohistology in normal hearts (without inﬂ
derline) myocarditis (G to I). Masson trichrome staining (A, D, G) re
stitial ﬁbrosis (blue areas) is obvious only in patients with chronic m
macrophages (C) are almost absent, T lymphocytes (E and H) and m
ditis and in lower numbers in chronic myocarditis.Figure 5 illustrates typical examples of histological
and immunohistological stainings. Whereas in unin-
flamed myocardium, inflammatory cells are absent
(Figs. 5A to 5C), high numbers of T-lymphocytes and
acrophages are found in cases with AMC (Figs. 5D
nd 5F), and lower amounts of infiltrating cells in
MC (Figs. 5G to 5I).
Statistical analysis. Data were tested for normal
distribution using the Kolmogorov-Smirnov test.
Normally distributed data are expressed as mean 
SD; non-normally distributed data are given as
median (interquartile range). Proportions are ex-
pressed as number of patients and percentages.
Unpaired samples between patient groups were
analyzed with the 2-tailed unpaired Student t test
or Mann-Whitney U test. Categorical variables
were compared using the Fisher exact test. All
statistical testing was based on a 2-sided alpha 
0.05 significance level.
Sensitivity, specificity, accuracy, positive predic-
tive value (PPV), and negative predictive value
(NPV) of the individual CMR sequences and the 2
of 3 approach were determined; the immunohisto-
logical EMB results were used as the reference
standard. As previously described (21), 95% confi-
dence intervals for sensitivity, specificity, and accu-
racy were calculated. The different sensitivities,
cute Myocarditis, and Chronic (Borderline) Myocarditis
ation) (A to C), acute myocarditis (D and F), and chronic (bor-
s severe myocyte necrosis in acute myocarditis (D), whereas inter-
carditis (G). Whereas in normal hearts, T lymphocytes (B) and
ophages (F and I) are detected in high amounts in acute myocar-ts, A
amm
veal
yo
acr
ECG  electrocardiogram
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518specificities, and accuracies were compared between
groups (patients with suspected AMC vs. CMC) as
independent proportions using the chi-square test
with continuity correction.
Statistical testing and data analysis were per-
formed with SPSS version 16 (SPSS, Inc., Chicago,
Illinois), R version 2.10 (R Development Core Team
2009, Vienna, Austria), and GraphPad Prism version
5.0b (GraphPad Software, San Diego, California).
R E S U L T S
Patient characteristics. Initially, 138 patients were
included in the study. EMB was found to be
nondiagnostic in 1 patient. Due to arrhythmia,
inability to perform breath-holds, or severe mo-
tion artifacts due to patients’ noncompliance,
initial steady-state free precession cine imaging
failed to provide reliable information on biven-
tricular volumes and function in 5 patients, and
CMR was therefore abandoned in these patients.
The final analyses were performed in 132
patients.
acteristics
All Patients
(N  132)
Group 1
(Symptoms <14 Days; n 
47 16 44 17
28 (21.2) 9 (13.0)
in days 14 (3–40) 3 (1–7)
90 (68.2) 39 (56.6)
110 (83.3) 57 (82.6)
20 (15.2) 6 (8.6)
39 (29.5) 21 (30.4)
78 (59.1) 47 (68.1)
45 (27–59) 52 (31–62)
ngs
23 (17.7) 9 (13.2)
n 45 (34.1) 39 (57.4)
ion 74 (56.1) 42 (61.8)
37 (38.5) 31 (51.7)
e-MB 42 (42.4) 35 (58.3)
tein 58 (68.2) 43 (86.0)
tors
59 (44.7) 27 (39.1)
35 (26.5) 24 (34.8)
12 (9.1) 3 (4.3)
19 (14.4) 9 (13.0)
ia 20 (15.2) 8 (11.6)
21 (15.9) 9 (13.0)
(%), or median (interquartile range).
; LV  left ventricle; MB  myocardial band.According to the above-mentioned criteria,
AMC was suspected in 70 patients (group 1) and
CMC in 62 patients (group 2). Within group 1, a
total of 37 patients (53%) met criteria for infarct-
like myocarditis. The patient characteristics are
shown in Table 2. The mean age within the total
population was 47  16 years. Patients with sus-
pected CMC were significantly older compared
with patients with suspected AMC (52  13 years
vs. 44  17 years; p  0.004). There were more
women in group 2 (19 vs. 9; p  0.02). The
majority of patients complained of fatigue, irrespec-
tive of duration of symptoms (82.6% and 88.3%
within groups 1 and 2, respectively). Dyspnea was
more often seen in group 2 (85.5% vs. 56.6% in
group 1; p  0.001), whereas chest pain was more
frequent in group 1 (68.1% vs. 51.7%; p  0.047).
Patients presenting with acute symptoms had a
higher frequency of elevated troponin, creatine
kinase-myocardial band, and C-reactive protein.
The cardiovascular risk factor profile was similar
between the 2 groups, apart from a higher fre-
quency of smokers in group 1 (34.8% vs. 18.3%;
p  0.047).
Group 2
(Symptoms >14 Days; n  62)
Group 1 vs. 2,
p Value
52 13 0.004
19 (30.6) 0.02
42 (28–90) 0.001
51 (85.5) 0.001
53 (88.3) 0.64
14 (23.3) 0.03
18 (30.0) 0.99
31 (51.7) 0.047
39 (25–55) 0.01
14 (23.7) 0.17
6 (10.2) 0.001
32 (54.2) 0.38
6 (17.1) 0.001
7 (17.9) 0.001
15 (44.1) 0.001
32 (53.3) 0.16
11 (18.3) 0.047
9 (15.0) 0.07
10 (16.7) 0.63
12 (20.0) 0.23
12 (20.0) 0.35Table 2. Patient Char
70)
Age, yrs
Female
Duration of symptoms
Symptoms
Dyspnea
Fatigue
Peripheral edema
Palpitations
Chest pain
LV ejection fraction
Pathological ECG ﬁndi
Block
ST-segment elevatio
ST-segment depress
Elevated troponin
Elevated creatine kinas
Elevated C-reactive pro
Cardiovascular risk fac
Hypertension
Smoker
Ex-smoker
Diabetes
Hyperlipoproteinem
Obesity
Values are mean  SD, n
3
p
c
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519EMB analysis. No procedural complications related to
EMB occurred. Details of EMB analysis are summa-
rized in Table 3. Within the total population, myo-
carditis was the most common diagnosis on EMB
analysis (62.9%). Signs of significant myocardial in-
flammation with evidence of myocardial injury/
necrosis (i.e., AMC) were observed in 5.3% and
without myocardial damage but with fibrosis (i.e.,
CMC) in 56.8% (Fig. 5); 1 patient (0.8%) had
Loeffler’s endomyocarditis. Within group 1, there was
a significantly higher incidence of myocarditis (75.7%
Table 3. Results of EMB
Myocardial inﬂammation consistent with myocarditis
Acute myocarditis (myocardial injury/necrosis)
Chronic myocarditis (ﬁbrosis/degeneration)
Loefﬂer’s endomyocarditis
Presence of virus genome
Latent virus genome presence in absence of inﬂammation
Healed myocarditis with no signiﬁcant myocardial inﬂammation
Hypertrophic cardiomyopathy
Dilated cardiomyopathy
Toxic cardiomyopathy
Amyloidosis
No pathological diagnosis
Values are n (%).
EMB  endomyocardial biopsy.
Virus Presence in 30.3% Virus Prese
All Patients
n = 132
Gro
n 
HHV6 + HHV7
HHV6
HHV7
PVB19
PVB19 + HHV6
PVB19 + HHV7
36%47.5%
27.5%
14%
10% 10%
4%2.5%
2.5%
Figure 6. Distribution of Cardiotropic Viruses Detected by Polym
Pie charts illustrate the distribution of cardiotropic viruses detec
biopsy (EMB) specimens. Viral genomes were detected in 30.3%
signiﬁcantly more often in group 1 compared with group 2 (40%
PVB19  parvovirus B19.vs. 48.4%; p 0.001). Viral genomes were detected in
0.3% (40 of 132) of patients within the total patient
opulation and significantly more often in group 1
ompared with group 2 (40.0% vs. 19.4%; p 0.013).
Distributions of cardiotropic viruses are illustrated in
Figure 6.
In the absence of inflammation/myocarditis, di-
lated cardiomyopathy was the most common histo-
pathological diagnosis (15.2% in the total popula-
tion; 22.6% in group 2 vs. 8.6% in group 1 [p 
0.029]).
ll Patients
Group 1
(Symptoms <14 Days)
Group 2
(Symptoms >14 Days
83 (62.9) 53 (75.7) 30 (48.4)
7 (5.3) 6 (8.6) 1 (1.6)
75 (56.8) 47 (67.1) 28 (45.2)
1 (0.8) – 1 (0.8)
40 (30.3) 28 (40.0) 12 (19.4)
4 (3.0) 1 (1.4) 3 (4.8)
8 (6.0) 4 (5.7) 4 (6.5)
4 (3.0) 1 (1.4) 3 (4.8)
20 (15.2) 6 (8.6) 14 (22.6)
1 (0.8) – 1 (1.6)
2 (1.5) – 2 (3.2)
10 (7.6) 5 (7.1) 5 (8.1)
 in 40.0%
p = 0.013
Virus Presence in 19.4%
 1 Group 2
n = 62
75%
29%
25%
14%
3%
ase Chain Reaction in EMB Specimens
using polymerase chain reaction in endomyocardial
of 132) of patients within the total patient population and
. 19.4%; p  0.013). HHV  human herpes virus;A )
Group 1 vs. 2,
p Value
0.001
0.07
0.01
0.29
0.013
0.34
0.99
0.06
0.029
0.47
0.22
0.99nce
up
= 70
er
ted
(40
vs
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520Results of CMR imaging. Within the total popula-
tion, left ventricular functional impairment (ejec-
tion fraction 50%) was observed in 79 patients
(59.8%). Median ejection fraction was 45% (inter-
quartile range 27% to 59%), whereas it was signif-
icantly lower in group 2 (39% vs. 52%; p  0.01).
A significant localized myocardial increase in T2
signal intensity (defined as focal myocardial edema)
was detected in 6 (4.5%) of 132 patients (6 of 6
within group 1). An ER 1.9 indicating global
myocardial edema was found in 61 of 132 patients
(37 of 70 in group 1 and 24 of 62 in group 2) (p 
0.12).
An increased gRE ratio 4 indicating myocar-
dial hyperemia was found in 81 of 132 patients (41
of 70 in group 1 and 40 of 62 in group 2) (p 
0.59).
Significant LGE was evident in 84 (63.6%)
patients (64.3% in group 1 and 62.9% in group 2)
(Table 4). LGE localization was predominantly
subepicardial in 50% of patients, intramyocardial in
33.3%, predominantly subendocardial in 7.1%, and
predominantly transmural in 9.5%; there were no
significant differences between groups 1 and 2.
With regard to regional distribution, LGE was
found to be located anteriorly in 23.5%, septally in
30.3%, laterally in 45.5%, and inferiorly in 46.2% of
patients. Overlap did occur.
Performance of CMR imaging for diagnosis of
myocarditis. The diagnostic performance, includ-
ing sensitivity, specificity, and accuracy for the
individual imaging techniques, is summarized in
Table 5. For the overall cohort, edema imaging
yielded sensitivity, specificity, and diagnostic accu-
racy values of 56%, 65%, and 59%, respectively.
Table 4. Extent and Localization of LGE on CMR Images
All Patients
Group
(Symptoms <
Presence of LGE 84 (63.6) 45 (64.3
Extent
Epicardial 42 (50.0) 25 (55.6
Intramyocardial 28 (33.3) 13 (28.9
Endocardial 6 (7.1) 1 (2.2)
Transmural 8 (9.5) 6 (13.3
Localization
Anterior 31 (23.5) 20 (28.6
Septal 40 (30.3) 17 (24.3
Lateral 60 (45.5) 38 (54.3
Inferior 61 (46.2) 34 (48.6
Values are n (%).
CMR  cardiac magnetic resonance; LGE  late gadolinium enhancement.Assessment of gRE for diagnosis of hyperemia and
capillary leakage had a higher sensitivity (74%) but
lower specificity, whereas accuracy was similar to
ER (60%). Equally, LGE imaging resulted in
sensitivity, specificity, and diagnostic accuracy val-
ues of 69%, 46%, and 61%, respectively.
The use of any 2 of the 3 parameters—gRE, ER,
or LGE—for CMR detection of myocarditis
yielded the highest diagnostic accuracy (68%) and
sensitivity (76%) but low specificity (54%). For all
parameters (ER, gRE, LGE, and the 2 of 3
approach), values for PPV were found to be higher
than for NPV.
Subgroup analyses. Using the 2 of 3 approach,
values for sensitivity, specificity, PPV, NPV, and
diagnostic accuracy within group 1 were 81%, 71%,
90%, 55%, and 79%, respectively. Apart from NPV,
which was found to be low in groups 1 and 2,
measures of diagnostic performance were higher in
group 1 compared with group 2 (p  0.02 for
accuracy, p  0.1 for sensitivity, and p  0.087 for
specificity). Within group 2, CMR for myocarditis
yielded markedly lower values for sensitivity (63%),
specificity (40%), PPV (53%), NPV (50%), and
diagnostic accuracy (52%). Highest values for diag-
nostic performance of CMR were seen within the
subgroup of patients with infarct-like myocarditis
(sensitivity, specificity, PPV, NPV, and diagnostic
accuracy 86%, 75%, 93%, 60%, and 84%,
respectively).
Assessing only those patients with viral positive
myocardial inflammation on EMB, sensitivity of
ER, gRE, LGE, and the 2 of 3 approach were 86%,
54%, 75%, and 82%, respectively.
ays)
Group 2
(Symptoms >14 Days)
Group 1 vs. 2,
p Value
39 (62.9) 0.99
17 (43.6) 0.35
15 (38.5) 0.52
5 (12.8) 0.1
2 (5.1) 0.28
11 (17.7) 0.16
23 (37.1) 0.13
22 (35.5) 0.04
27 (43.5) 0.61
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To the best of our knowledge, this is the largest
prospective study on CMR in patients with clini-
cally suspected AMC and CMC in which a com-
prehensive CMR protocol including assessment of
edema, hyperemia, and fibrosis was applied. The
study was conducted according to proposed stan-
dards of image acquisition, analyses, and interpre-
tation (14).
In this study, we demonstrated a satisfactory
diagnostic performance of CMR in suspected
AMC. The best values of diagnostic performance
were found in patients with suspected infarct-like
AMC. In contrast, the diagnostic performance of
CMR in patients with suspected CMC was found
to be insufficient.
Patients with suspected AMC. Rigorous data of
CMR evaluated against the currently considered
gold standard of EMB for the diagnosis of myocar-
ditis in consecutive, unselected patients are limited.
Due to the lack of data, current recommendations
reflect the best achievable expert consensus based
on currently available literature. As suggested by the
CMR consensus paper (14), the 2 of 3 approach
yields the best diagnostic accuracy compared with
the individual imaging techniques. So far, there is
Table 5. Diagnostic Performance of CMR Compared With EMB
Study Group Sensitivity
Total population (N  132)
ER 56 (45–66)
gRE 74 (65–84)
LGE 69 (59–78)
2 of 3 approach 76 (67–85)
Group 1 (n  70)
ER 64 (51–77)
gRE 76 (64–87)
LGE 74 (62–85)
2 of 3 approach 81 (71–92)
Infarct-like myocarditis (n  37)
ER 69 (52–86)
gRE 79 (65–94)
LGE 83 (69–97)
2 of 3 approach 86 (74–99)
Group 2 (n  62)
ER 42 (26–59)
gRE 73 (58–88)
LGE 61 (44–77)
2 of 3 approach 63 (46–79)
Values are % (95% conﬁdence interval) or %.
ER  edema ratio; gRE  global relative enhancement; NPV  negative predictivonly 1 report on CMR in patients with acutesymptoms of myocarditis using the 2 of 3 approach
with a reported sensitivity, accuracy, and PPV of
76%, 85%, and 95%, respectively (5). These find-
ings are comparable to our results (81%, 79%, and
90%). In contrast, values for specificity and NPV in
our study were lower compared with the study by
Abdel-Aty et al. (5) (specificity 71% vs. 96%; NPV
55% vs. 79%). These differences are mainly attrib-
uted to a lower specificity and NPV of LGE and
gRE assessment. Especially for LGE, a wide variety
of diagnostic accuracies in myocarditis has been
reported, ranging from 50% to 96% (4,5,7,9,12,
13,17). Some general considerations of LGE imag-
ing have to be taken into account when diagnostic
performance of LGE in myocarditis is discussed.
Pathophysiologically, the finding of LGE in myo-
carditis is considered to specifically reflect irrevers-
ible injury (i.e., myocardial necrosis and/or fibrosis).
However, myocarditis may not always lead to large
enough necrotic regions to be visually detectable.
Accordingly, LGE may be insensitive for detection
of symptomatic myocarditis with limited or very
subtle myocyte necrosis and inflammation as well as
in patients with nonfocal irreversible injury. In our
study, the majority of patients with myocardial
inflammation were classified as having CMC in the
eciﬁcity PPV NPV Accuracy
(51–79) 75 44 59 (51–67)
(19–46) 67 41 60 (51–68)
(31–60) 70 44 61 (52–69)
(40–69) 76 54 68 (60–76)
(42–87) 85 37 63 (53–76)
(29–77) 83 41 70 (59–81)
(42–87) 87 44 71 (61–82)
(49–92) 90 55 79 (69–88)
(29–96) 87 36 68 (52–83)
(29–96) 89 46 76 (62–90)
(29–96) 76 50 78 (65–92)
(45–100) 93 60 84 (72–96)
(48–100) 58 50 55 (41–66)
(6–100) 51 40 48 (36–61)
(17–100) 51 44 48 (36–61)
(22–100) 53 50 52 (39–64)
lue; PPV  positive predictive value; other abbreviations as in Tables 3 and 4.Sp
65
33
46
54
65
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65
71
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63
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21
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40presence of chronic inflammation and fibrosis but
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522absence of acute myocyte necrosis, which at least
partially explains the low NPV of LGE imaging.
Furthermore, LGE cannot be considered to be
specific to myocarditis, as it has been described in
various pathologies including myocardial infarction,
in patients with dilated or hypertrophic cardiomy-
opathy, or amyloidosis (22). Therefore, false-
positive results are to be expected and will reduce
the specificity of this imaging technique. This
finding is reflected in a pooled analysis of studies
using LGE sequences for diagnosis of myocarditis,
reporting a mediocre accuracy of 68% (14), which is
in keeping with the 71% accuracy found in our
patient population.
Values of diagnostic performance of gRE in
patients with suspected AMC were slightly lower
than reported in previous studies, particularly the
case for specificity and NPV. Previous studies
(5,7,8,10) clearly differ in terms of validation of
CMR findings (clinical vs. EMB), patient charac-
teristics, and duration of patients’ symptoms, which
complicates a fair comparison to our study. How-
ever, general limitations of this imaging technique
are its susceptibility for artifacts, especially in pa-
tients with arrhythmia and irregular breathing pat-
terns (14). Other drawbacks of gRE include the
following: 1) increased gRE is not specific to
myocarditis (23–25); 2) the coincidence of skeletal
muscle myositis (26) and thereby increases in skel-
etal muscle signal intensity can cause pseudo-
normalization of the gRE ratio, resulting in falsely
negative results; and 3) the development of focal
hyperemia (27) can be missed and can result in
falsely negative gRE values. Thus, the low NPV of
gRE assessment in our study might therefore not be
surprising.
The diagnostic performance of T2-weighted
edema imaging was similar to previous reports. As
stated earlier for LGE and gRE imaging, assess-
ment of myocardial edema on T2-weighted images
s not specific to myocarditis but can occur in other
athologies associated with myocardial infiltration
nd/or injury (28,29). The low signal-to-noise ratio
ight hamper diagnostic performance (14). These
imitations are likely to prohibit a better perfor-
ance of this imaging sequence in myocarditis.
ewer sequences, especially T2 mapping, may over-
come these limitations with subsequent better di-
agnostic accuracy (29).
In previous studies (5,7), the combined use of all
3 tissue-based CMR parameters and application of
the 2 of 3 approach (13) resulted in the best overall
diagnostic accuracy. The results of our study inpatients with AMC strongly support such a com-
bined and comprehensive CMR approach in these
patients. The highest values of diagnostic perfor-
mance were found in the subgroup of patients with
infarct-like myocarditis. This finding might be
explained by a higher degree of acuteness and
manifestation of the disease. This is reflected in
troponin release and marked electrocardiogram
changes in this patient cohort. It seems reasonable
to expect a higher degree of myocardial edema,
hyperemia, and myocardial injury in these patients,
which may result in an improved diagnostic perfor-
mance of CMR compared with patients with bor-
derline or chronic disease.
Patients with suspected CMC. Reports on CMR in
uspected CMC are scarce. In a previous retrospec-
ive study, a fair diagnostic performance of CMR
as been reported (7). These results could not be
onfirmed in this larger prospective study, in which
iagnostic performance of CMR was found to be
nsufficient. Within the chronic group, the findings
f a long duration of symptoms before referral, very
ubtle changes in C-reactive protein, troponin, and
reatine kinase-myocardial band, and in particular
he very low incidence of immunohistologically
MC (n  1) are suggestive of mild inflammation
nly in this cohort. Consequently, the extent of
yocardial edema and hyperemia as signs of acute
yocardial injury are likely to be subtle, which
ight explain the high percentage of falsely nega-
ive CMR results in this cohort. In addition, these
inor myocardial changes cannot be differentiated
rom fibrosis in the myocardium, which develops as
consequence of myocarditis. Furthermore, EMB
esults demonstrate a marked heterogeneity of pa-
hologies in this group. As stated before, CMR
equences can be falsely positive in noninflamma-
ory cardiomyopathies with fibrotic areas, which
ight explain the reduced specificity and accuracy
f CMR in this study. Results of CMR in patients
ith CMC are presumed to depend on patient
election, incidence of myocarditis, and severity of
isease. Clearly, further studies are needed to define
he capacity of CMR in the diagnosis of CMC.
owever, when currently proposed methodological
tandards are applied in a real-world scenario,
MR does not seem to reliably confirm or omit the
iagnosis of myocarditis in patients with chronic
ymptoms.
Justiﬁcation of the Lake Louise criteria. In 2008, a
task force of the Society for Cardiovascular Mag-
netic Resonance summarized imaging protocol rec-
ommendations in the setting of suspected myocar-
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523ditis (30). Within these recommendations, the
presence or absence of LGE forms the integral
diagnostic criterion, whereas edema imaging is
optional and gRE more controversial. As pointed
out earlier, LGE but also ER and gRE sequences
are not specific to myocarditis. Therefore, studies
have suggested using a 2 of 3 approach, which is
also referred to as the Lake Louise criteria. We have
now demonstrated that diagnostic accuracy using
the 2 of 3 approach is higher compared with using
LGE imaging only. Although there are significant
limitations of CMR in myocarditis at present,
regardless of which sequences and criteria are ap-
plied, the superior accuracy of the 2 of 3 approach
supports the use of these criteria rather than LGE
and optional T2 imaging only, as suggested by the
earlier recommendations (30).
Clinical implications. The results of this study sug-
gest that CMR adds significantly to the diagnostic
work-up in patients with suspected AMC. On the
basis of the high PPV, a pathological CMR scan in
the setting of suspected AMC can be considered
to be diagnostic in 9 of 10 patients. Due to the
low NPV of CMR in suspected AMC, negative
CMR results do not entirely exclude the diagno-
sis of myocarditis, and further diagnostic testing
might be advisable.
In patients with suspicion of CMC, the diagnos-
tic performance of CMR has to be considered as not
sufficient to guide clinical management. Therefore, at
present, CMR in these patients cannot be recom-
mended for diagnosis confirmation or exclusion.
Study limitations. A general limitation of all diag-
ostic studies in patients with suspected myocarditis
s the lack of consensus for the diagnosis of myo-
arditis. In the last few years, it turned out that the
allas criteria are not sufficient to differentiate
arious forms of AMC and CMC (31). Although
he introduction of quantitative immunohisto-
hemistry has improved the assessment of inflam-
atory heart diseases, there is still controversy
bout the relevance of viral genomes. Although it is
ell known that myocarditis is mostly induced by
iruses, viral genomes in our study were present in
ess than one-half of patients with myocardial
nflammation (48%), which is consistent with pre-
ious reports (7,17). Whereas absence of viral ge-
omes in myocarditis might be explained by rele-onsidered that in a certain percentage of patients,
n efficient early immune response can restrict
ardiac viral replication, and very low numbers of
iral copies are not detectable using current
ethods.
The use of left ventricular EMBs only in our
tudy represents a possible limitation. In a recent
eport, the combination of left and right ventric-
lar EMBs was suggested to be superior to left
entricular EMB only (17). Furthermore, acquir-
ng right ventricular EMB represents the pre-
ominant approach at some centers. Therefore,
iagnostic performance of CMR might differ
hen compared with right ventricular or biven-
ricular EMB.
Across equal setups and parameters of CMR
equences, algorithms used on different scanners
nd vendors can differ, which could result in some
ariation of signal intensity and results of image
nalyses. Therefore, we cannot exclude the possi-
ility that diagnostic performance of CMR ac-
uired in a comparable patient population but on a
ifferent scanner might differ.
CMR image acquisition, analysis, and interpreta-
ion were made according to the JACC Consensus
hite Paper and recommendations on the use of
MR for myocarditis (14). Findings of this study
ight not be applicable when using other recommen-
ations on CMR (30) in this patient population.
Finally, our findings reflect the performance of
MR when only diagnostic scans are considered,
hereas nondiagnostic scans were not included in
he analyses.
C O N C L U S I O N S
The results of this study underline the usefulness of
CMR for assessment of myocardial inflammation/
myocarditis in patients with suspected AMC. In
contrast, with the current criteria, techniques, and
sequences, the diagnostic performance of CMR in
patients with suspected CMC is not sufficient to
guide clinical management.
Reprint requests and correspondence: Dr. Philipp Lurz,
niversity of Leipzig–Heart Center, Department of In-
ernal Medicine/Cardiology, Struempellstrasse 39, 04289
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‹ A P P E N D I X
For a detailed description of the image acquisi-
tion and analyses protocols applied in this
study, please see the online version of this
article.
